H.R.744: Medical Innovation Act of 2015

About This Bill

Bill Summary

Medical Innovation Act of 2015 This bill amends the Public Health Service Act to require certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a settlement agreement in the previous five years with a federal agency regarding specified violations...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.744.

Bill Actions

Date Description
Feb. 6, 2015
Referred to the Subcommittee on Health.
Feb. 4, 2015
Referred to the House Committee on Energy and Commerce.
Feb. 4, 2015

Introduced in the House by Chris Van Hollen (D-Md.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page